Market Place
Sourcing Support
Kelun-Biotech`s SKB264 Study Results Presented At CSCO Congress
28 Sep 2024 //
PR NEWSWIRE
Kelun-Biotech Releases Three SKB264 Study Abstracts At ESMO 2024
09 Sep 2024 //
PR NEWSWIRE
Merck Bags Kelun ADC For $37.5M, Boots Out Another Asset
20 Aug 2024 //
FIERCE BIOTECH
Kelun-Biotech`s TROP2-ADC SKB264 Gets Second NDA Accepted In China
20 Aug 2024 //
PR NEWSWIRE
Merck discontinues some cancer drug development with China`s Sichuan Kelun
24 Oct 2023 //
REUTERS
Merck builds out cancer drug pipeline with Kelun-Biotech deal
23 Dec 2022 //
BIOPHARMADIVE
Kelun-Biotech Announces Research Collaboration and License Agreement with MSD
26 Jul 2022 //
GLOBENEWSWIRE
Sichuan Kelun-Biotech, Levena are to Present Positive Clinical Progress of A166
01 Jun 2022 //
GLOBENEWSWIRE
Merck acquires global rights to cancer drug from Kelun in $1.4B deal
18 May 2022 //
BIOWORLD
Chinese company establishes drug factory in Almaty
24 Nov 2015 //
XINHUANET
Chinese pharmaceutical firms recall ginkgo biloba products
04 Jun 2015 //
YAHOO NEWS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.